Rubius Therapeutics laid off most of its staff as it explores a sale. Rubius Therapeutics is in the final days of its existence. The company is laying off 82% of its workforce and will begin looking at a sale or merger. (Boston Business Journal)

Anti-obesity drug Wegovy helped teens lose weight, according to new research. Wegovy is currently available by prescription only for adults in the U.S., but teens in the study who took the drug lost an average of almost 15% of their body weight. (TODAY)

A study suggested ‘considerable’ monkeypox transmission happens before symptoms. This is the first evidence indicating the virus can be transmitted this way, contradicting previous thoughts that monkeypox was almost entirely spread by people who were already sick. (Reuters)

The Centers for Disease Control and Prevention said it wants to change the ‘antiquated’ rules that hamper the agency’s ability to fight COVID, polio and other diseases. CDC Director Dr. Rochelle Walensky plans to appeal to Congress to allow for flexibility to do this kind of hiring in a crisis, similar to the authority vested in some other federal agencies. (CNN)
A congressional report found the healthcare sector ‘uniquely vulnerable’ to cyberattacks. It recommends that the federal government improve the country’s cybersecurity risk posture in the healthcare sector, help the private sector mitigate cyber threats and assist healthcare providers in responding and recovering from cyberattacks. (The Hill)